{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:25:28Z","timestamp":1648743928414},"reference-count":42,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2022.1514","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T08:52:20Z","timestamp":1645692740000},"source":"Crossref","is-referenced-by-count":0,"title":["A novel model of dermatomyositis induced by membrane antigen and calciphylaxis in rats"],"prefix":"10.3892","volume":"16","author":[{"given":"Xin","family":"Zhao","sequence":"first","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Ge","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongya","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayong","family":"Cai","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"issue":"597","key":"key20220303101321_b1-BR-16-4-01514","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-597","article-title":"Trends in dermatomyositis- and polymyositis-related mortality in the state of Sao Paulo, Brazil, 1985-2007: Multiple cause-of-death analysis","volume":"10","author":"Santo","year":"2010","journal-title":"BMC Public Health"},{"key":"key20220303101321_b2-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.rmed.2014.09.003","article-title":"Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type","volume":"108","author":"Johnson","year":"2014","journal-title":"Respir Med"},{"key":"key20220303101321_b3-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: Clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"key20220303101321_b4-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/DAD.0b013e31818520e1","article-title":"Dermatomyositis: A clinicopathological study of 40 patients","volume":"31","author":"Smith","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"key20220303101321_b5-BR-16-4-01514","author":"Vermaak"},{"key":"key20220303101321_b6-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cca.2018.03.042","article-title":"Advances in biomarkers for dermatomyositis","volume":"482","author":"Yang","year":"2018","journal-title":"Clin Chim Acta"},{"key":"key20220303101321_b7-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semarthrit.2020.11.009","article-title":"Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020","volume":"51","author":"Sun","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"key20220303101321_b8-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11926-011-0166-x","article-title":"Pathogenesis of dermatomyositis: Role of cytokines and interferon","volume":"13","author":"Kao","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"key20220303101321_b9-BR-16-4-01514","first-page":"770","article-title":"An experimental model of \u2018dermatomyositis\u2019 induced by calciphylaxis","volume":"85","author":"Selye","year":"1961","journal-title":"Can Med Assoc J"},{"issue":"e04866","key":"key20220303101321_b10-BR-16-4-01514","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04866","article-title":"Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis","volume":"6","author":"Aljabban","year":"2020","journal-title":"Heliyon"},{"key":"key20220303101321_b11-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bbadis.2014.05.034","article-title":"Dermatomyositis, polymyositis and immune-mediated necrotising myopathies","volume":"1852","author":"Luo","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key20220303101321_b12-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1136\/annrheumdis-2020-218661","article-title":"Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1\u03b3 can result in experimental myositis","volume":"80","author":"Okiyama","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"key20220303101321_b13-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48-49","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun"},{"key":"key20220303101321_b14-BR-16-4-01514","author":"Shimojima"},{"key":"key20220303101321_b15-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/bjd.15655","article-title":"Calciphylaxis in haemodialysed patients: Diagnostic value of calcifications in cutaneous biopsy","volume":"178","author":"Cassius","year":"2018","journal-title":"Br J Dermatol"},{"key":"key20220303101321_b16-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s0014-4800(03)00003-0","article-title":"Skeletal muscle myosin is the autoantigen for experimental autoimmune myositis","volume":"74","author":"Nemoto","year":"2003","journal-title":"Exp Mol Pathol"},{"key":"key20220303101321_b17-BR-16-4-01514","first-page":"14457","article-title":"Development of an improved animal model of experimental autoimmune myositis","volume":"8","author":"Kang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20220303101321_b18-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J Exp Med"},{"key":"key20220303101321_b19-BR-16-4-01514","author":"Abbas"},{"key":"key20220303101321_b20-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","article-title":"Four dermatomyositis-specific autoantibodies-anti-TIF1\u04af, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","volume":"13","author":"Bodoki","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"240","key":"key20220303101321_b21-BR-16-4-01514","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1737-2","article-title":"Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis","volume":"20","author":"Ishikawa","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"key20220303101321_b22-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"657","DOI":"10.21873\/invivo.11108","article-title":"Elevated IL-4 and IFN-\u04af levels in muscle tissue of patients with dermatomyositis","volume":"31","author":"Giris","year":"2017","journal-title":"In Vivo"},{"key":"key20220303101321_b23-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s2255-5021(13)70010-5","article-title":"Dermatomyositis and polymyositis: From immunopathology to immunotherapy (immunobiologics)","volume":"53","author":"Shinjo","year":"2013","journal-title":"Rev Bras Reumatol"},{"key":"key20220303101321_b24-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/14397595.2018.1467257","article-title":"Current diagnosis and treatment of polymyositis and dermatomyositis","volume":"28","author":"Sasaki","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"100018","key":"key20220303101321_b25-BR-16-4-01514","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100018","article-title":"Polymyositis and dermatomyositis-challenges in diagnosis and management","volume":"2","author":"Yang","year":"2019","journal-title":"J Transl Autoimmun"},{"key":"key20220303101321_b26-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"key20220303101321_b27-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/S0140-6736(03)14862-3","article-title":"Diagnostic criteria for polymyositis and dermatomyositis","volume":"362","author":"Miller","year":"2003","journal-title":"Lancet"},{"key":"key20220303101321_b28-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J Clin Invest"},{"key":"key20220303101321_b29-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/j.ajkd.2015.01.034","article-title":"Calciphylaxis: Risk factors, diagnosis, and treatment","volume":"66","author":"Nigwekar","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"1067","key":"key20220303101321_b30-BR-16-4-01514","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60235-X","article-title":"Calciphylaxis","volume":"383","author":"Zhou","year":"2014","journal-title":"Lancet"},{"key":"key20220303101321_b31-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2016.05.044","article-title":"Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-\u03b1","volume":"251","author":"Aghagolzadeh","year":"2016","journal-title":"Atherosclerosis"},{"key":"key20220303101321_b32-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/pmj.77.911.557","article-title":"Calciphylaxis","volume":"77","author":"Mathur","year":"2001","journal-title":"Postgrad Med J"},{"key":"key20220303101321_b33-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/rheumatology\/ker307","article-title":"Systemic lupus erythematosus risk factors for coronary artery calcifications","volume":"51","author":"Romero-D\u00edaz","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"key20220303101321_b34-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.anai.2017.07.013","article-title":"Evaluation of periprocedural hypersensitivity reactions","volume":"119","author":"Iammatteo","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20220303101321_b35-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","article-title":"Diagnosis and management of anaphylaxis in precision medicine","volume":"140","author":"Castells","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"key20220303101321_b36-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.fct.2017.06.004","article-title":"A protocol for a systematic review to identify allergenic tree nuts and the molecules responsible for their allergenic properties","volume":"106","author":"Javed","year":"2017","journal-title":"Food Chem Toxicol"},{"key":"key20220303101321_b37-BR-16-4-01514","first-page":"67","article-title":"Dermatomyositis: An association of gingival telangiectases and anti Jo-1 antibody in the adult","volume":"16","author":"Dourmishev","year":"2007","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"160","key":"key20220303101321_b38-BR-16-4-01514","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.03.94","article-title":"MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis","volume":"5","author":"Sontheimer","year":"2017","journal-title":"Ann Transl Med"},{"key":"key20220303101321_b39-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"key20220303101321_b40-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cyto.2014.11.026","article-title":"The role of type I interferons and other cytokines in dermatomyositis","volume":"73","author":"Arshanapalli","year":"2015","journal-title":"Cytokine"},{"issue":"179180","key":"key20220303101321_b41-BR-16-4-01514","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/179180","article-title":"New onset of dermatomyositis\/polymyositis during anti-TNF-\u03b1 therapies: A systematic literature review","volume":"2014","author":"Brunasso","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"key20220303101321_b42-BR-16-4-01514","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1002\/art.24039","article-title":"Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis","volume":"58","author":"Mamyrova","year":"2008","journal-title":"Arthritis Rheum"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T08:22:41Z","timestamp":1646295761000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2022.1514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2,24]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2022.1514","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"31"}}